Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 0 | 0 | 0 | 33 |
| Gross Profit | N/A | 0 | N/A | N/A | 33 |
| Operating Expenses | 7,722 | 6,714 | 6,878 | 4,790 | 6,386 |
| Operating Income | -7,722 | -6,714 | -6,878 | -4,790 | -6,353 |
| Other Income | 1,744 | 15 | 41 | -1 | 1,397 |
| Pre-tax Income | -5,978 | -6,699 | -6,837 | -4,791 | -4,956 |
| Net Income Continuous | -5,978 | -6,699 | -6,837 | -4,791 | -4,956 |
| Net Income | $-5,978 | $-6,699 | $-6,837 | $-4,791 | $-4,956 |
| EPS Basic Total Ops | -1.50 | -1.50 | -1.50 | -1.00 | -1.50 |
| EPS Basic Continuous Ops | -1.38 | -1.57 | -1.59 | -1.17 | -1.22 |
| EPS Diluted Total Ops | -1.50 | -1.50 | -1.50 | -1.00 | -1.50 |
| EPS Diluted Continuous Ops | -1.38 | -1.57 | -1.59 | -1.17 | -1.22 |
| EBITDA(a) | $-7,450 | $-6,432 | $-6,618 | $-4,553 | $-6,101 |